Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 inhibitors, GLP-1 receptor agonists, and more.

Incorporating metformin in burn metabolic care may help control hyperglycemia and broader metabolic dysfunction linked to ...

Deborah J. Wexler, MD, MSc, and colleagues reviewed recent shifts in diabetes care, such as SGLT2i and GLP-1 RA medications.

When the core set of symptoms are the same, how can you tell diabetes type 1.5, or LADA, apart from it's famous cousins?

But, should your kidneys fail to work properly, your GP will recommend discontinuing metformin and switching to a different ... its deficiency can lead to nerve damage, resulting in sensations of ...

USA: A retrospective comparative effectiveness study among veterans with type 2 diabetes found that three GLP-1 receptor agonists — semaglutide, liraglutide, and dulaglutide—showed similar risks for ...

In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...

Researchers say GLP-1 drugs prescribed for weight loss like Ozempic and Mounjaro are more effective at reducing heart health ...

A comparative effectiveness study of glucose-lowering drugs finds the GLP-1 receptor agonists most protective against ...

CHICAGO -- A series of large, real-world analyses supported benefit of GLP-1 receptor agonists in cardiopulmonary indications for patients with type 2 diabetes, researchers reported at the CHEST ...

Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular events.

These 52-week data reinforce HTD1801's potential as a truly differentiated therapeutic to concurrently address metabolic ...